Skip to main content
Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
15.39
+0.61 (4.09%)
At close: Nov 11, 2026, 4:00 PM EST
15.22
-0.16 (-1.07%)
Pre-market: Nov 12, 2026, 5:22 AM EST

Iambic Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Market Capitalization
729--
Market Cap Growth
---
Enterprise Value
527--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.030.040.05
Net Debt / Equity Ratio
-1.25-1.13-1.04
Net Debt / EBITDA Ratio
2.052.162.56
Net Debt / FCF Ratio
2.972.913.94
Asset Turnover
-0.05-
Quick Ratio
4.516.928.41
Current Ratio
4.596.988.52
Return on Equity (ROE)
--54.21%-
Return on Assets (ROA)
--29.35%-
Return on Capital Employed (ROCE)
-53.10%-48.80%-38.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
--0.93%-
SEC Filings: 10-K · 10-Q